NIOSH National Center of Excellence for the Prevention of Childhood Agricultural Injury (U54)
Forecast
Centers for Disease Control and Prevention - ERA plans to offer grants of up to $1.6 million to any type of organization. It expects to make one award worth $8.0 million in total. It is a forecast: the notice is expected around December 4, 2026, with applications due around March 3, 2027.
From the official notice on Grants.gov, last changed July 29, 2026. Checked October 31, 2026.
- Award ceiling$1.6 million
- Award floornot stated
- Expected awards1
- Total funding$8.0 million
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Forecast posted | July 15, 2026 |
|---|---|
| Expected posting | December 4, 2026 |
| Expected deadline | March 3, 2027 |
| Expected award date | August 30, 2027 |
Add the deadline to your calendar
Who can apply
This opportunity is open to any type of organization.
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the HHS Grants Policy Statement, are not allowed.
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
The National Institute for Occupational Safety and Health (NIOSH) is committed to addressing a wide range of occupational health and safety hazards affecting those who work in the agriculture, forestry, and fishing (AgFF) sector. Children and adolescents ("youth") are consistently more likely to be fatally injured working in agriculture compared to other industries. While many steps have been taken to prevent youth injuries in AgFF work, there remains a need for a consistent national program to study and improve their safety, health, and well-being. This notice of funding opportunity (NOFO) will support a National Center of Excellence for the Prevention of Childhood Agricultural Injury and Illness ("the National Children's Center"). The National Children's Center will engage in high-quality research, education, outreach, and effective translation of scientific discoveries into practice for the benefit of youth living and working in AgFF communities. The activities of the National Children's Center will: Improve the collection and analysis of injury, illness, and fatality data for youth working and living in AgFF environments. Enhance research and practice to identify and address gaps in the evidence base for youth workers across AgFF communities, and especially those in rural areas. Engage in comprehensive intervention and implementation studies to improve AgFF youth safety, health, and well-being. Evaluate the use of technology, including AI and automation, to mitigate workplace hazards and improve health outcomes for AgFF youth. Expand outreach and collaboration at the local, regional, and national level to disseminate information and best practices. The National Children's Center works closely with NIOSH AgFF program leadership; other NIOSH Centers for Agriculture, Forestry, and Fishing Safety and Health; NIOSH intramural scientists (when applicable); academic and research partners; industry and community groups; and other organizations to advance research integration, inform best practices, and develop effective worksite solutions for youth and families working and living in AgFF environments across the U.S. The Center should clearly demonstrate capacity to maintain a national scope for research, implementation, dissemination, and related activities.
How to apply
- Read the full notice and attachments on Grants.gov. The notice is the official source for deadlines and requirements.
- Make sure your organization has an active SAM.gov registration and Unique Entity ID; registration can take several weeks.
- Register on Grants.gov and submit through Workspace before the deadline and time given in the notice. Our application guide walks through each step.
Questions go to Jessica MK Streit, Scientific Program Official, jstreit@cdc.gov, 513-533-8107.
Questions people ask
Who can apply for NIOSH National Center of Excellence for the Prevention of Childhood Agricultural Injury (U54)?
Centers for Disease Control and Prevention - ERA accepts applications from any type of organization. The notice adds further conditions, so read its eligibility section.
What is the deadline for NIOSH National Center of Excellence for the Prevention of Childhood Agricultural Injury (U54)?
Expected deadline March 3, 2027. Confirm the date and time in the official notice on Grants.gov.
How much funding is available?
Awards of up to $1.6 million each. About $8.0 million in total for one award.
Similar open grants
- Continuation of the Collaborative Islet Transplantation Registry (U01 Clinical Trial Not allowed)
- BRAIN Initiative Cell Atlas Network (BICAN): Coordinating Unit for Biostatistics, Informatics, and Engagement (CUBIE)
- Centers without Walls for mechanisms of neurodegeneration in Alzheimer’s disease-related dementias (ADRD)
- Expanding the Therapeutic Pipeline for Treating and Preventing Alzheimer's Disease and Related Dementias: Preclinical Validation and Drug Discovery for Novel Candidate Targets (U01 Clinical Trial Not Allowed)
- Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE, RP1 Clinical Trial Not Allowed)
- Exposomic Contributions to ADRD Pathology and Resilience